Please provide your email address to receive an email when new articles are posted on . The addition of lorazepam to haloperidol reduced symptoms of agitated delirium among individuals with advanced ...

Caring for patients who are facing stress, anxiety and depression, or when physical restraint is required, is one of the several challenges that healthcare professionals face in the clinical setting.

Janine E. Curcio and Dr. Robert Lowe provide a seven-point scale based on speech and responsiveness to decide whether or not to use sedation for an agitated patient. Managing an agitated or aggressive ...

Agitation is the third most common neuropsychiatric symptom observed in patients with dementia, with 30% of patients exhibiting these symptoms; the frequency increases to 80% among patients living in ...

Julieta* grew weaker as her illness progressed. She was a frail, 4'11", elderly woman battling terminal cancer who began punching the air, trying to assert control over an unfamiliar reality. As her ...

Droperidol 5 mg reduces the need for rescue sedation more effectively than 10 mg in patients with agitation who visit the emergency department (ED). "In this large cohort of patients in which ...

Agitation is a neuropsychiatric symptom in patients with Alzheimer's disease (AD), the most common form of dementia. The prevalence of this symptom is about 40%-65% ...

Use of lorazepam-based regimens reduced persistent restlessness and agitation associated with end-of-life delirium in cancer patients, a randomized study showed. Among 72 patients in a palliative care ...

Results from a Phase 3 clinical study for treatment of agitation in patients with Alzheimer’s dementia showed that patients treated with brexpiprazole had a statistically significantly greater ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...